Boost Your Thinking Skills with Combined Therapy for MS

Credibility

Interest

Key Takeaway

Combining cognitive rehabilitation and neurofeedback therapy can significantly improve thinking skills in people with MS.

What They Found

The study tested three different groups: one doing cognitive rehabilitation, one doing neurofeedback, and one doing both together. The group that combined both therapies showed the best results in tasks that needed attention and quick thinking. For example, they could switch their focus between tasks faster than the others. Even a month after finishing the training, this group still performed better than those who only did one type of therapy. This suggests that using both methods together can help keep your thinking skills sharp over time.

Who Should Care and Why

MS patients who struggle with thinking and memory can benefit from these findings, as they show a way to improve these skills. Caregivers can also use this information to support their loved ones in finding effective therapies. Just like using both a hammer and a screwdriver can help build a strong house, combining these therapies may strengthen brain function. Healthcare providers should consider these combined treatments to help their patients manage symptoms better. Overall, these findings could change daily routines for MS patients, making everyday tasks easier and more manageable.

Important Considerations

The study only included adult females, so the findings may not apply to everyone with MS. Also, the combined therapy may not work for all patients, as individual responses can vary. It's important for MS patients to discuss with their healthcare providers whether these therapies are right for them.

Categories:

Mental Wellness Living with MS Early Research

Article Topics:

Cognitive flexibilityCognitive rehabilitation therapyExecutive functionMultiple sclerosisNeurofeedback therapy

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News